1. Home
  2. INBS vs BOLT Comparison

INBS vs BOLT Comparison

Compare INBS & BOLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Intelligent Bio Solutions Inc.

INBS

Intelligent Bio Solutions Inc.

HOLD

Current Price

$1.62

Market Cap

6.5M

Sector

Health Care

ML Signal

HOLD

Logo Bolt Biotherapeutics Inc.

BOLT

Bolt Biotherapeutics Inc.

N/A

Current Price

$7.11

Market Cap

7.7M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
INBS
BOLT
Founded
2016
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Medical Specialities
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.5M
7.7M
IPO Year
2019
2021

Fundamental Metrics

Financial Performance
Metric
INBS
BOLT
Price
$1.62
$7.11
Analyst Decision
Buy
Analyst Count
0
4
Target Price
N/A
★ $29.00
AVG Volume (30 Days)
★ 34.9K
20.3K
Earning Date
11-11-2026
11-11-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
$1,980,484.00
★ $7,695,000.00
Revenue This Year
$44.72
N/A
Revenue Next Year
$44.26
$2,525.07
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ 0.07
52 Week Low
$0.54
$3.10
52 Week High
$24.90
$7.20

Technical Indicators

Market Signals
Indicator
INBS
BOLT
Relative Strength Index (RSI) 43.59 83.18
Support Level $1.52 $3.53
Resistance Level $1.92 $7.16
Average True Range (ATR) 0.11 0.48
MACD 0.04 0.22
Stochastic Oscillator 56.72 85.22

Price Performance

Historical Comparison
INBS
BOLT

About INBS Intelligent Bio Solutions Inc.

Intelligent Bio Solutions Inc is a medical technology company focused on developing and delivering intelligent, rapid, non-invasive testing and screening solutions. Its current active product is the Intelligent Fingerprinting Platform, consisting of a proprietary portable platform that analyzes fingerprint sweat using a one-time cartridge and portable handheld reader. Its flagship product, the Intelligent Fingerprinting Drug Screening System, is a two-part system of non-invasive, fingerprint sweat-based diagnostic testing products designed to detect drugs of abuse, including opiates, cocaine, methamphetamines, benzodiazepines, cannabis, methadone, and buprenorphine. The Company operates in APAC, the UK, the Americas, and the rest of the world, with maximum revenue from the United Kingdom.

About BOLT Bolt Biotherapeutics Inc.

Bolt Biotherapeutics Inc is a clinical-stage biopharmaceutical company developing novel immunotherapies for the treatment of cancer. The company is focused on the clinical development of BDC-4182, its claudin 18.2 ISAC. Its other pipeline programs include CEA ISAC program a Boltbody ISAC targeting carcinoembryonic antigen cell adhesion molecule 5, or CEA; PD-L1 ISAC utilizes a novel human anti-PD-L1 antibody conjugated to a next-generation TLR7/8 agonist payload via a non-cleavable linker; and BDC-3042, its dectin-2 agonist antibody program, developed to repolarize critical cells in the tumor microenvironment known as tumor associated macrophages. It operates in single segment.

Share on Social Networks: